Literature DB >> 34053054

Characterization of Cytotoxic T Lymphocytes (CTL) by Tissue Microarray.

Giuseppe Stefano Netti1, Monica Rutigliano2, Chiara Divella3, Giuseppe Lucarelli2.   

Abstract

Tissue microarray (TMA) is a smart technical innovation recently imposed in pathology research. This technology provides a high-throughput analysis of multiple tissues at the same time. The technique allows faster analysis and considerably reducing costs for the staining because many small representative tissue samples from hundreds of different cases are assembled on a single histologic slide. This versatile technique may improve conventional microscopic techniques to detect and characterize cytotoxic T lymphocytes (CTL). Immunohistochemistry (IHC) may be effectively employed in CTL characterization to identify the location and distribution of target antigens in tissues by staining with a specific antibody. The antibody may be conjugated to either a fluorescent or enzymatic label, and the location of the label seen through a microscope approximates the position of the target antigen.This article summarizes the technical aspects of tissue microarray construction and sectioning, advantages, application, and limitations associated with immunohistochemistry and immunofluorescence.

Entities:  

Keywords:  Immunofluorescence; Immunohistochemistry; Paraffin-embedded tissue; Tissue microarray

Year:  2021        PMID: 34053054     DOI: 10.1007/978-1-0716-1507-2_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  LPS removal reduces CD80-mediated albuminuria in critically ill patients with Gram-negative sepsis.

Authors:  Giuseppe Stefano Netti; Fabio Sangregorio; Federica Spadaccino; Francesco Staffieri; Antonio Crovace; Barbara Infante; Annamaria Maiorano; Giulia Godeas; Giuseppe Castellano; Anna Maria Di Palma; Clelia Prattichizzo; Antonella Cotoia; Lucia Mirabella; Loreto Gesualdo; Gilda Cinnella; Giovanni Stallone; Elena Ranieri; Giuseppe Grandaliano
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-23

2.  JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients.

Authors:  Elisabetta Cavalcanti; Margherita Gigante; Vito Mancini; Michele Battaglia; Pasquale Ditonno; Carmela Capobianco; Raffaele I Cincione; Francesco P Selvaggi; Wolfgang Herr; Walter J Storkus; Loreto Gesualdo; Elena Ranieri
Journal:  J Biomed Biotechnol       Date:  2010-03-22

3.  Application of Tissue Microarray in Esophageal Adenocarcinoma.

Authors:  Nassim Saremi; Alfred K Lam
Journal:  Methods Mol Biol       Date:  2018

4.  Semaphorin 3F expression is reduced in pregnancy complicated by preeclampsia. An observational clinical study.

Authors:  Giovanni Stallone; Maria Matteo; Giuseppe Stefano Netti; Barbara Infante; Adelaide Di Lorenzo; Clelia Prattichizzo; Stefania Carlucci; Federica Trezza; Loreto Gesualdo; Pantaleo Greco; Giuseppe Grandaliano
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

5.  ATMAD: robust image analysis for Automatic Tissue MicroArray De-arraying.

Authors:  Hoai Nam Nguyen; Vincent Paveau; Cyril Cauchois; Charles Kervrann
Journal:  BMC Bioinformatics       Date:  2018-04-19       Impact factor: 3.169

Review 6.  Tissue Microarray: A rapidly evolving diagnostic and research tool.

Authors:  Nazar M T Jawhar
Journal:  Ann Saudi Med       Date:  2009 Mar-Apr       Impact factor: 1.526

7.  Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation.

Authors:  Maddalena Gigante; Marilena d'Altilia; Eustacchio Montemurno; Sterpeta Diella; Francesca Bruno; Giuseppe S Netti; Elena Ranieri; Giovanni Stallone; Barbara Infante; Giuseppe Grandaliano; Loreto Gesualdo
Journal:  BMC Nephrol       Date:  2013-03-18       Impact factor: 2.388

8.  A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD).

Authors:  Luisa Santangelo; Maddalena Gigante; Giuseppe Stefano Netti; Sterpeta Diella; Flora Puteo; Vincenza Carbone; Giuseppe Grandaliano; Mario Giordano; Loreto Gesualdo
Journal:  BMC Nephrol       Date:  2014-03-03       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.